BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1264 related articles for article (PubMed ID: 29670281)

  • 1. Identification of the tumour transition states occurring during EMT.
    Pastushenko I; Brisebarre A; Sifrim A; Fioramonti M; Revenco T; Boumahdi S; Van Keymeulen A; Brown D; Moers V; Lemaire S; De Clercq S; Minguijón E; Balsat C; Sokolow Y; Dubois C; De Cock F; Scozzaro S; Sopena F; Lanas A; D'Haene N; Salmon I; Marine JC; Voet T; Sotiropoulou PA; Blanpain C
    Nature; 2018 Apr; 556(7702):463-468. PubMed ID: 29670281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.
    Pastushenko I; Mauri F; Song Y; de Cock F; Meeusen B; Swedlund B; Impens F; Van Haver D; Opitz M; Thery M; Bareche Y; Lapouge G; Vermeersch M; Van Eycke YR; Balsat C; Decaestecker C; Sokolow Y; Hassid S; Perez-Bustillo A; Agreda-Moreno B; Rios-Buceta L; Jaen P; Redondo P; Sieira-Gil R; Millan-Cayetano JF; Sanmatrtin O; D'Haene N; Moers V; Rozzi M; Blondeau J; Lemaire S; Scozzaro S; Janssens V; De Troya M; Dubois C; Pérez-Morga D; Salmon I; Sotiriou C; Helmbacher F; Blanpain C
    Nature; 2021 Jan; 589(7842):448-455. PubMed ID: 33328637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition.
    Latil M; Nassar D; Beck B; Boumahdi S; Wang L; Brisebarre A; Dubois C; Nkusi E; Lenglez S; Checinska A; Vercauteren Drubbel A; Devos M; Declercq W; Yi R; Blanpain C
    Cell Stem Cell; 2017 Feb; 20(2):191-204.e5. PubMed ID: 27889319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of epithelial-mesenchymal transition in cancer pathology.
    Guarino M; Rubino B; Ballabio G
    Pathology; 2007 Jun; 39(3):305-18. PubMed ID: 17558857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
    Celià-Terrassa T; Meca-Cortés O; Mateo F; Martínez de Paz A; Rubio N; Arnal-Estapé A; Ell BJ; Bermudo R; Díaz A; Guerra-Rebollo M; Lozano JJ; Estarás C; Ulloa C; Álvarez-Simón D; Milà J; Vilella R; Paciucci R; Martínez-Balbás M; de Herreros AG; Gomis RR; Kang Y; Blanco J; Fernández PL; Thomson TM
    J Clin Invest; 2012 May; 122(5):1849-68. PubMed ID: 22505459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion.
    Gardberg M; Kaipio K; Lehtinen L; Mikkonen P; Heuser VD; Talvinen K; Iljin K; Kampf C; Uhlen M; Grénman R; Koivisto M; Carpén O
    PLoS One; 2013; 8(9):e74923. PubMed ID: 24086398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
    Liao TT; Yang MH
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
    Ding W; You H; Dang H; LeBlanc F; Galicia V; Lu SC; Stiles B; Rountree CB
    Hepatology; 2010 Sep; 52(3):945-53. PubMed ID: 20564331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition.
    Zhao N; Powell RT; Yuan X; Bae G; Roarty KP; Stossi F; Strempfl M; Toneff MJ; Johnson HL; Mani SA; Jones P; Stephan CC; Rosen JM
    Nat Commun; 2021 Jul; 12(1):4262. PubMed ID: 34253738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
    Diepenbruck M; Christofori G
    Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition in tumor metastasis.
    Yeung KT; Yang J
    Mol Oncol; 2017 Jan; 11(1):28-39. PubMed ID: 28085222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
    Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch-1-mediated esophageal carcinoma EC-9706 cell invasion and metastasis by inducing epithelial-mesenchymal transition through Snail.
    Wang T; Xuan X; Pian L; Gao P; Hu H; Zheng Y; Zang W; Zhao G
    Tumour Biol; 2014 Feb; 35(2):1193-201. PubMed ID: 24022665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
    Sinha D; Saha P; Samanta A; Bishayee A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state.
    Cui J; Zhang C; Lee JE; Bartholdy BA; Yang D; Liu Y; Erler P; Galbo PM; Hodge DQ; Huangfu D; Zheng D; Ge K; Guo W
    Nat Cell Biol; 2023 Jan; 25(1):145-158. PubMed ID: 36604594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.
    Bullock MD; Sayan AE; Packham GK; Mirnezami AH
    Biol Cell; 2012 Jan; 104(1):3-12. PubMed ID: 22188537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.